SCHEDULE: RA Capital Divests Entire RxSight Stake

RA Capital Management and its affiliates have reported a 0.0% beneficial ownership in RxSight, Inc., indicating a full divestment of their previous holdings.

Summary

• RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (collectively, the "Reporting Persons") now beneficially own 0.00 shares of RxSight, Inc. Common Stock.
• This represents 0.0% of the outstanding Common Stock, par value $0.001 per share, of RxSight, Inc.
• The event requiring this Schedule 13G/A filing occurred on September 30, 2025.
• The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.

Sentiment

Score: 3

Explanation: The complete divestment by RA Capital Management and its affiliates of their stake in RxSight, Inc. is generally perceived as a negative signal, although no specific reasons for the divestment are provided in the filing.

Negatives

• RA Capital Management and its affiliates have completely divested their beneficial ownership in RxSight, Inc., reducing their stake to 0.0%.

Risks

• The complete divestment by a significant institutional investor like RA Capital Management could signal a loss of confidence in RxSight, Inc.'s future prospects, potentially leading to negative market sentiment and share price decline.

Future Outlook

No forward-looking statements or guidance regarding RxSight, Inc.'s operations or financial performance are provided by the reporting persons in this filing.

Management Comments

• The Reporting Persons certify that, to the best of their knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, and were not acquired or held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing primarily concerns a change in beneficial ownership by a specific institutional investor and does not provide broader industry context or analysis of RxSight, Inc.'s competitive position.

Stakeholder Impact

• Shareholders may react negatively to the news of a significant institutional investor completely divesting its stake, potentially leading to a decrease in share price due to perceived loss of confidence.

Key Dates

Recommendation

The complete divestment by RA Capital Management, a prominent healthcare investor, of its entire stake in RxSight, Inc. suggests a loss of confidence or a strategic reallocation away from the company. While the filing does not provide reasons, such a significant exit by an informed investor typically signals potential underlying issues or a belief that the stock's future performance will be unfavorable, warranting a 'sell' recommendation.

Keywords

RxSight, RA Capital Management, Peter Kolchinsky, Rajeev Shah, Schedule 13G, beneficial ownership, divestment, common stock, institutional investor